USPTO 2015–2025 USPTO PatentsView US Corporation

In2Bones USA, LLC

USPTO PatentsView assignee record - 45 granted patents across 4 technology areas, recorded in grant years 2018–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

RSS updates for this company

The verdict

According to USPTO PatentsView, In2bones ranks #7,281 of 49,997 tracked US assignees by granted-patent volume, with 45 patents across 4 technology areas.

#7,281
of 49,997 US assignees by volume
Top 41%
by Innovation Score (38.3/100)
12.3
avg claims per patent
+825%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R7281 · US Corporation #7,281 · 45 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-SMALL 45 grants
  • UPPER-Q #7,281/49,997
  • PHOTO-FINISH Ii-vi Incorporated
  • CPC-NARROW A61B · 4 areas
  • INNOV-THIN 38.3/100
  • CLAIMS-RICH 12.3 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-SURGE +825% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Ii-vi Incorporated (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How In2bones’s 38.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around In2bones

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows In2bones's Innovation Score is 38.3/100 (top 41% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for In2bones?

Each dot is one of In2bones’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). In2bones’s own 12.3 claims/patent is at or below the 15.5 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

In2bones vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 44.945.045.04545.045.045.1 0510152025 Granted patents (volume) Avg claims / patent Ii-vi Incorporated - 45, 15.53Ii-vi IncorporatedIntelligent Fusion Technology, Inc. - 45, 16.38Intelligent Fusio…Intevac, Inc. - 45, 17.56IntevacIllinois Institute of Technology - 45, 17.98Illinois Institut…Indian Industries, Inc. - 45, 10.42Indian IndustriesIntelligent Technologies International, Inc. - 45, 20.82Intelligent Inter…International Fruit Genetics, LLC - 45, 1International Fru…J.SCHMALZ GMBH - 45, 13.38J SchmalzIn2Bones USA, LLC - 45, 12.27In2bones USA
In2bones vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where In2bones's grants concentrate

In2Bones USA, LLC is a focused PatentsView assignee: 4 CPC subclasses with 100% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2024 (11 grants) versus a trough of 2 in 2018. By volume, In2bones sits between Ii-vi Incorporated and J.SCHMALZ GMBH.

In2bones's three-year grant acceleration

In2Bones USA, LLC shows 24 grants in 2022–2024 against only 15 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at In2Bones's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows In2Bones holds 45 patents at rank #7,281, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near In2Bones

By rank, the assignees closest to #7,281 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in In2Bones's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for In2Bones, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), In2Bones ranks #425 of 7,127 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (38 here).

In2bones's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

38 Top 41% higher than 59% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

024681012 20182019202020212022202320242025 4
USPTO utility patent grants by year · 2018–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table
In2Bones USA, LLC patent grants by year, 2015–2025
Year Patents Granted Share of Period
2018 2 4.4%
2019 2 4.4%
2020 8 17.8%
2021 5 11.1%
2022 9 20.0%
2023 4 8.9%
2024 11 24.4%
2025partial year 4 8.9%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

In2Bones USA, LLC's patent record in context - here's where to go next.

  • In2Bones USA, LLC's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 100% of its portfolio - see every assignee active in that class. Explore A61B
  • Ranked #7,281 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare In2Bones USA, LLC against Ii-vi Incorporated, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 38.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.